Last reviewed · How we verify
Placebo of Quick-Acting Heart Reliever — Competitive Intelligence Brief
marketed
Cardiovascular
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo of Quick-Acting Heart Reliever (Placebo of Quick-Acting Heart Reliever) — Guang'anmen Hospital of China Academy of Chinese Medical Sciences. A placebo formulation with no active pharmaceutical ingredient, used as a control or comparative reference in clinical settings.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo of Quick-Acting Heart Reliever TARGET | Placebo of Quick-Acting Heart Reliever | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo of Quick-Acting Heart Reliever CI watch — RSS
- Placebo of Quick-Acting Heart Reliever CI watch — Atom
- Placebo of Quick-Acting Heart Reliever CI watch — JSON
- Placebo of Quick-Acting Heart Reliever alone — RSS
Cite this brief
Drug Landscape (2026). Placebo of Quick-Acting Heart Reliever — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-of-quick-acting-heart-reliever. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab